CR Elley, T Kenealy, E Robinson, PL Drury - Diabetic Medicine, 2008 - interscience.wiley.com Methods A prospective cohort study including people with Type 2 diabetes but no
previous CVD. The primary outcome measure was time to first recorded fatal or
non-fatal CVD event (ischaemic heart disease, cerebrovascular accident, ... Cited by 4 - Related articles - All 3 versions
N Tumosa - Clinics in geriatric medicine, 2008 - fafp.org Multiple visual complications accompany diabetes mellitus (DM) of long duration.
The most common complications include numerous ocular and periocular changes
that characterize diabetic retinopathy. These changes are characterized by ... Cited by 2 - Related articles - View as HTML - All 44 versions
[CITATION] Management of Eye Disease and Visual Loss
F Biscetti, G Straface, V Arena, E Stigliano, G … - Cardiovascular Diabetology, 2009 - pubmedcentral.nih.gov By using a hindlimb ischemia murine model, in this study we have found that
pioglitazone restores the blood flow recovery and capillary density in ischemic
muscle of diabetic mice and that this process is associated with increased ... Related articles - All 6 versions
A Botts, M Munshi - Current Cardiovascular Risk Reports, 2008 - Springer The association of diabetes and cardiovascular disease is a major health concern
in the elderly population. Patients 65 years of age or older with diabetes have
a greater risk of ischemic heart disease and cardiovascu- lar mortality ... Related articles
C Rosak, G Mertes - Current Diabetes Reviews, 2009 - ingentaconnect.com Abstract: The alpha-glucosidase inhibitor acarbose is administered to control
blood glucose levels in type 2 diabetic pa- tients and, in several countries, in
those with impaired glucose tolerance. The efficacy and safety of the drug ... Related articles - All 2 versions